Orchestra BioMed Ownership | Who Owns Orchestra BioMed?


OverviewForecastRevenueFinancialsChart

Orchestra BioMed Ownership Summary


Orchestra BioMed is owned by 47.23% institutional investors, 16.19% insiders, and 36.58% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 21.63% of OBIO shares.

OBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOrchestra BioMed47.23%16.19%36.58%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp8.31M21.63%$22.26M
Perceptive advisors4.59M11.96%$12.31M
Blackrock funding, inc. /de681.35K1.77%$1.83M
Knoll capital management455.13K1.19%$169.82K
Knott david m jr100.00K0.26%$268.00K
Lasry marc60.87K0.16%$163.13K
Marshall wace, llp49.47K0.13%$132.57K
Y-intercept (hong kong)45.45K0.12%$121.80K
Newedge advisors44.08K0.11%$118.14K
Hrt financial lp28.22K0.07%$75.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lasry marc60.87K0.91%$163.13K
Perceptive advisors4.59M0.46%$12.31M
Rtw investments, lp8.31M0.32%$22.26M
Knott david m jr100.00K0.12%$268.00K
Knoll capital management455.13K0.12%$169.82K
Point72 asia (singapore) pte.18.71K0.01%$50.14K
Able financial group13.40K0.01%$35.92K
Y-intercept (hong kong)45.45K0.00%$121.80K
Xtx topco16.82K0.00%$45.07K
Newedge advisors44.08K0.00%$118.14K

Top Buyers

HolderShares% AssetsChange
Knoll capital management455.13K0.12%455.13K
Knott david m jr100.00K0.12%100.00K
Rtw investments, lp8.31M0.32%99.90K
Marshall wace, llp49.47K0.00%49.47K
Y-intercept (hong kong)45.45K0.00%45.45K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de681.35K--1.26M
Bank of new york mellon---52.49K
Rhumbline advisers---31.66K
Millennium management---21.51K
Deutsche bank ag\---20.22K

New Positions

HolderShares% AssetsChangeValue
Knoll capital management455.13K0.12%455.13K$169.82K
Knott david m jr100.00K0.12%100.00K$268.00K
Marshall wace, llp49.47K0.00%49.47K$132.57K
Y-intercept (hong kong)45.45K0.00%45.45K$121.80K
Newedge advisors44.08K0.00%44.08K$118.14K

Sold Out

HolderChange
True wealth design-6.00
Gamma investing-101.00
Russell investments group-125.00
Sterling capital management-247.00
Northwestern mutual wealth management-447.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025585.45%18,134,637-4.51%471.91%3552.17%16-11.11%
Mar 31, 2025548.00%18,940,1491.07%492.00%22-31.25%18157.14%
Dec 31, 20245210.64%19,199,4870.91%512.00%3425.93%7-22.22%
Sep 30, 2024472.17%19,025,94933.83%503.21%27-10.00%928.57%
Jun 30, 2024469.52%14,216,9936.62%392.86%3076.47%7-58.82%

Recent Insider Transactions


DateNameRoleActivityValue
Aug 25, 2025Fain Eric S-Buy$15.03K
Aug 25, 2025Sherman Darren See RemarksBuy$7.86K
Aug 21, 2025Hochman David P See RemarksBuy$14.94K
Aug 25, 2025Taylor Andrew Lawrence Chief Financial OfficerBuy$5.10K
Aug 04, 2025RTW INVESTMENTS, LP-Buy$363.64

Insider Transactions Trends


DateBuySell
2025 Q38-
2025 Q221
2025 Q1--
2024 Q43-
2024 Q368

OBIO Ownership FAQ


Who Owns Orchestra BioMed?

Orchestra BioMed shareholders are primarily institutional investors at 47.23%, followed by 16.19% insiders and 36.58% retail investors. The average institutional ownership in Orchestra BioMed's industry, Biotech Stocks , is 306.59%, which Orchestra BioMed falls below.

Who owns the most shares of Orchestra BioMed?

Orchestra BioMed’s largest shareholders are Rtw investments, lp (8.31M shares, 21.63%), Perceptive advisors (4.59M shares, 11.96%), and Blackrock funding, inc. /de (681.35K shares, 1.77%). Together, they hold 35.37% of Orchestra BioMed’s total shares outstanding.

Does Blackrock own Orchestra BioMed?

BlackRock is not among the top 10 institutional shareholders of Orchestra BioMed.

Who is Orchestra BioMed’s biggest shareholder by percentage of total assets invested?

Lasry marc is Orchestra BioMed’s biggest shareholder by percentage of total assets invested, with 0.91% of its assets in 60.87K Orchestra BioMed shares, valued at 163.13K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools